Announcements Trials
Browse Landscape

Phase

Phase NA 17Phase 2 4Phase 3 2Phase 1/2 2Phase 1 1

Status

Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 1Colorectal Neoplasms 1Barrett Esophagus 1Adenomatous Polyposis Coli 1Adenocarcinoma of the Esophagogastric Junction 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Endoscopy, Digestive System × Clear all
NCT04939051 2026-05-13

Obeticholic Acid for Prevention in Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT06557733 2026-05-13

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT06782048 2025-01-17

Use of Pyrvinium to Reverse Stomach Precancerous Conditions

National University Hospital, Singapore

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02287129 2023-11-28

MEMORI

Technical University of Munich

Phase 2 Completed
75 enrolled
Gastrointestinal

Adenocarcinoma of the Esophagogastric Junction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡